Exicure Corp (XCUR) - Earnings per share increase in current year

Official company branding of Exicure (XCUR)

Exicure, Inc. specializes in the development of DNA-based drugs, leveraging the intellectual potential of scientists and option programs. This GURU.Markets chart, illustrating the annual percentage growth of net income per share, recorded a figure of 0.00. This occurs against a backdrop of strict reagent transportation and the necessity to restore patent protection following asset restructuring.

XCUR Exicure, Inc. Earnings per share growth in current year (07/04/2022 - 11/15/2026)

Comprehensive metric breakdowns and analytics for Exicure, Inc. (XCUR)

- stock value and consensus price forecast:
Market Price Exicure, Inc.|XCUR - Consensus Target
- market capitalization indicators:
Market Value Exicure|XCUR - Enterprise Value
- business book valuation details:
Net Assets per Share Exicure|XCUR - Company Book Value|Capitalization to Book Value Ratio exicuretx.com|XCUR - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Exicure, Inc.|XCUR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient Exicure, Inc.|XCUR - Company Total Debt|Debt to Book Value Ratio Exicure|XCUR - Company Long-Term Debts|Company Current Liabilities Exicure|Quick Ratio exicuretx.com
- earnings and multiples data:
XCUR - Company Net Income|Expected Net Income Exicure, Inc.|XCUR - P/E Multiple|Price to Future Earnings Ratio Exicure Corp|XCUR - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Exicure|XCUR - Operating profit EBITDA|Net earnings per share (EPS TTM) Exicure|XCUR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months exicuretx.com|XCUR - Net earnings per share growth this year|Projected earnings per share growth rate for next year Exicure, Inc.
- revenue and sales proceeds data:
XCUR - Revenue and Sales Volume|Company Future Sales Exicure Inc.|XCUR - P/S Multiple|Forward Price-to-Revenue Multiple Exicure Inc.
Summary company analysis:Exicure, Inc.
Core merchandise of Exicure Corp

Exicure, Inc. (XCUR) is transitioning to a patent licensing model to reduce R&D capital expenditures. Analyzing the annual growth of the company's net income per share allows for an assessment of this transformation's efficiency. This metric measures the percentage change in EPS, revealing the real trend of business value through market noise. Growth in this indicator confirms profit scaling amid low costs. It is critical for investors to utilize this momentum to determine their investment horizon.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|PRQR: Earnings per share trend in current year|Earnings growth in current year CDXS (codexis.com)|SGMO: Earnings per share growth this year|NAUT: Net earnings per share growth this year|Earnings per share growth rate in current year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Earnings per share growth in current year|Earnings per share growth rate in current year Generation Bio Corp (GBIO)|Net earnings per share growth this year BOLD|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year